Shenzhen Keli Bio-Medical Technology Co., Ltd (hereinafter referred to as "Keli Medical") has been committed to the development and manufacture of medical equipment since its inception in 2002, covering ultrasound medical imaging, endoscopy and minimally invasive diagnostics, in vitro diagnostic series of three major product lines.
Currently, the company has seven R&D centers in Silicon Valley, Seattle, Tokyo, Japan, and Shenzhen, Shanghai, Harbin, and Wuhan, China, and has invested about 20% of its annual revenue in R&D in the past three years.